As the Center for Musculoskeletal Research (CMSR) has grown since its inception in 2000, a key component of the strategic plan has been to compliment the strong record of R01 funding earned by faculty with synergistic programmatic supports. This strategic initiative had its first successes in 2003 with Program Project-level funding to study Pb toxicity in the skeleton (P01 to Dr. Edward Puzas) and in 2006 to understand the molecular pathways that are potential therapeutic targets in the context of skeletal trauma (P50 in 2006 to Dr. Randy Rosier, renewed in 2012 to Dr. Regis J. O'Keefe, O'Keefe Lab). Additionally, in 2006, NIH Training Grant funding was awarded (T32 to Dr. Regis J. O’Keefe, O'Keefe Lab) to provide support to 4 pre-doctoral and 2 post-doctoral trainees. In 2011, this Program was renewed and expanded to include 2 additional Biomedical Engineering pre-doctoral slots (T32 renewal to Dr. Michael J. Zuscik, Zuscik Lab). Also in 2011, a Core Center grant (P30 to Dr. Edward Schwarz, Schwarz Lab) was awarded that provides key infrastructure supports in addition to a robust Pilot Project Grant Program that will assist junior faculty in their pursuit of independence.
See the activities of these programs using the links below:
P50 - Centers of Research Translation (CORT), AR054041
T32 – Training in Musculoskeletal Science, AR053459
P30 – Core Center for Musculoskeletal Biology and Medicine, AR069655
AOTrauma sponsored Clinical Priority Program (CPP)